Abstract Purpose: We have reported previously that the expression of E. coli dUTPase (dutE) can protect HT29 cells from 5-¯uorodeoxyuridine (FdUrd)-induced DNA fragmentation and cytotoxicity. In the study reported here, we further characterized the ability of dutE expression in one HT29 clone, dutE7, to alter the eects of treatment with FdUrd and other thymidylate synthase (TS) inhibitors. In addition, we developed two HuTu80 dutE-expressing clones using a pLNCX-dutE retroviral construct and tested their sensitivity to FdUrd-induced DNA fragmentation and cytotoxicity. Methods: Both a dutE retroviral expression system and a dutE antibody were developed to facilitate the generation and screening of dutE-expressing clones. HT29 and HuTu80 clones expressing dutE were tested for drug-induced DNA damage with either alkaline elution or pulsed ®eld gel electrophoresis and drug-induced loss of clonogenicity.
Introduction
The¯uoropyrimidines, particularly 5-¯uorouracil and 5-uorodeoxyuridine (FdUrd) are the most widely used agents for treating gastrointestinal tumors. One initial biochemical lesion induced by these drugs is inhibition of the enzyme thymidylate synthase (TS) via formation of a covalent ternary complex comprising TS, FdUMP and reduced folate cofactor. TS inhibition has two immediate consequences that are thought to be important in the eventual loss of cellular viability: depletion of dTTP, resulting in DNA synthesis inhibition [13] , and an accumulation of the enzyme's substrate, dUMP, which is further phosphorylated to dUTP [8] . When dTTP levels are depressed, dUTP is readily incorporated into DNA where it is subsequently excised by the enzyme uracil DNA glycosylase [8, 9, 17] . If no dTTP is available to ®ll the excised portion of DNA, dUTP will once again be incorporated and excised. This recurring process of uracil misincorporation and misrepair (also called the`futile repair cycle') is thought to lead eventually to irreversible DNA fragmentation and loss of clonogenic capacity [9, 14, 21] .
The enzyme dUTPase provides the cell with one line of defense against this`futile repair cycle' [2, 10] . dUTPase catalyzes the conversion of dUTP to dUMP, inhibiting the accumulation of dUTP associated with TS inhibition. Previous work in our laboratory has shown that excess dUTPase activity is associated with a natural form of resistance to TS inhibitors [4] and has also demonstrated that exogenously expressed E. coli dUTPase (dutE) partially protects HT29 cells from FdUrdinduced cytotoxicity and DNA damage [5] .
To better understand the potential therapeutic signi®cance of dUTPase expression in the context of TS inhibition, we expanded our studies to determine the pharmacological speci®city of the eects of exogenously expressed dUTPase in HT29 cells, as well as the cell-line speci®city of dUTPase protection from the cytotoxic eects of TS inhibition.
Materials and methods

Cell culture and drug solutions
Con3 and dutE7 are clonal derivatives of the HT29 human carcinoma cell line which express either the neomycin resistance gene or dutE, respectively [5] . Con3, dutE7 and HuTu80 clones (derived from a second human carcinoma cell line, HuTu80) were maintained in McCoy's 5 A medium (Gibco, Grand Island, NY) supplemented with 10% fetal bovine serum (Intergen, Purchase, NY) and 2 nM L-glutamine (Sigma, St. Louis, MO) at 37°C in an atmosphere containing 5% CO 2 . GP+E86 and GP+envAM12 cells are ecotropic (E86) and amphotropic (AM12) retroviral producer cell lines grown under similar conditions in DMEM (Gibco, Grand Island, NY) supplemented with 10% calf serum (Intergen) and 2 nM L-glutamine [18, 19] . FdUrd, 2-chlorodeoxyadenosine (2-CdA), and methotrexate (MTX; Sigma) were each dissolved in Hank's buered saline solution (Gibco) and stored at 4°C for up to 2 months. MTX was stored in the dark. CB3717 was dissolved in 10 mM NaHCO 3 and stored at A20°C.
Retrovirus-mediated transduction of cells for expression of dutE
The dutE gene was excised from a previously described pUC.dutE plasmid [5] with EcoRI and ligated into pGEM7zf+ (Promega, Madison, Wis.) at the EcoRI multiple cloning site. The sense dUTPase gene was removed from pGEM7.dutE with ClaI and XhoI, gel isolated and cloned into a modi®ed pLNCX retroviral vector between the ClaI and XhoI cloning sites. pLNCX.dutE complemented BW286 bacterial cells at the restrictive temperature [7] .
pLNCX.dutE was transfected into ecotropic producer GP+E86 cells using DOTAP transfection reagent (Boerhinger Mannheim). The resultant G418-resistant clones were screened by Western blot analysis for dutE expression and retroviral supernatant from a clone expressing high levels of dutE was used to infect amphotropic producer GP+envAM12 cells in the presence of 8 lg/ ml polybrene. Conditioned medium from one AM12 dutE clone was subsequently used to infect HuTu80 cells as described above. Two HuTu80 clones, 80 C and 80 K, selected by Western blot analysis for expression of high levels of dutE, were further screened for dUTPase activity and FdUrd sensitivity (Fig. 1 ).
Development of a dutE polyclonal antibody
The dutE gene was cloned into a glutathione S-transferase-conjugating expression vector, pGEXKT at the BamHI cloning site [11] . The resultant construct, pGEX.dutE, was used to transform BL21 E. coli, a protease-de®cient strain used to generate large amounts of protein [12] . The dutE-glutathione-S-transferase fusion protein (dutE-GST) was puri®ed by anity chromatography using glutathione agarose [11] and assayed for catalytic activity as described below. Puri®ed dutE-GST was sent to Cocalico Biologicals (Reamstown, Pa.) for use in generating rabbit anti-dutE polyclonal antibody sera.
DutE western blot analysis
Cellular proteins were separated by SDS-PAGE on a 12% polyacrylamide gel, transferred to a polyvinylidene di¯uoride membrane (Millipore Immobilon-P) and probed with a 1:5000 dilution of rabbit dutE-antiserum in 1% milk/20 mM Tris, 500 mM NaCl, 0.1% Tween-20 (TTBS). After washing with TTBS, the blots were incubated ®rst with a 1:2000 dilution of biotin-conjugated goat antirabbit IgG (Sigma) and then with a 1:2000 dilution ExtrAvidinalkaline phosphatase complex (Sigma), washing again with TTBS between incubations. The dutE band was visualized with nitroblue tetrazolium, 5-bromo-4-chloro-3-indolyl phosphate precipitation (Sigma).
Measurement of dUTPase catalytic activity
Cell extracts were assayed for dUTPase activity as described by measuring the conversion of [5- 3 H]dUTP to [5- 3 H]dUMP [4] . Cells were harvested and resuspended at 5´10 7 cells/ml extraction buer (0.01 M Tris HCl, pH 7.5, 2 mM b-mercaptoethanol, 4 mM MgCl 2 , 10% glycerol and 0.2 mM phenylmethylsulfonyl¯uoride) prior to freeze-thawing and sonication. Sonicated extracts, adjusted to 0.15 M KCl, were centrifuged at 13 000 g for 10 min at 4°C, diluted to 0.2 lg protein/ll extraction buer, and stored at A70°C. For kinetic dUTPase assays, protein extracts were incubated with 0.05 M Tris HCl, pH 7.5, 4 mM MgCl 2 , 25 mM NaF, 2 mM bmercaptoethanol, 0.1 mM dUTP and 0.05 lCi/ml [5- 3 H]dUTP. Reaction mixtures were incubated at 37°C for 0±15 min, then boiled for 1 min to stop the reaction. Samples (10 ll each) were run out on a thin-layer chromatography sheet (Polygram Cel 300 PEI UV 254 ; Alltech, Deer®eld, Ill.) previously spotted with 10 mM Following separation, the amount of radioactivity in each deoxyuridine nucleotide fraction was determined by scintillation counting. Enzyme activity was calculated by determining the fraction of radioactivity from each sample in the dUMP form. Total pilomoles of dUMP formed were plotted versus time of incubation and the slope of the resulting line used to determine a rate of enzyme activity in picomoles formed per minute per microgram protein.
Clonogenic assays
Cells were trypsinized and plated at a density of 20 000 cells/cm 2 . After 48 h, medium supplemented with dialyzed fetal bovine serum (Gibco) and the appropriate drug concentration was added to the cells. (Cells were treated with at least ten times the IC 50 for growth inhibition as determined after a 48-h drug treatment.) Drug medium on 48-h samples was replenished after 24 h. At 24 or 48 h, cells were trypsinized and replated in 10 lM thymidine medium (except CdA experiments) to restore thymidine levels. After a further 12 days, surviving colonies were ®xed with a 3:1 methanol/ acetic acid solution and stained with trypan blue. Surviving fractions represent the plating eciency for a given timepoint divided by the control plating eciency. Control plating eciencies were 0.6±0.8 for dutE7 cells, 0.3±0.5 for con3 cells and 0.4±0.6 for HuTu80-derived clones.
DNA fragmentation analysis with pulsed ®eld gel electrophoresis (PFGE)
Cells were plated as above with the addition of a 24-h labeling period with 0.1 lCi/ml [2- 14 C]thymidine [0.15 lCi/ml; 56 mCi/ mmol; Moravek Biochemicals, Brea, Calif.] and a 16-h chase period prior to drug treatment. Cells were resuspended at 10 7 cells/ml as described previously [3] in a ®nal concentration of 0.7% low melting point agarose (BRL). Cell blocks containing 2±3´10 5 cells were loaded onto a 0.7% agarose gel (Bio-Rad) and analyzed with PFGE using a CHEF DR-II apparatus. Samples were run in 14°C recirculating 0.5´TBE buer (45 mM Tris borate/1 mM EDTA, pH 8.0) at 1.9 V/cm with a reorientation angle of 120°. The switching interval was ramped linearly from 1200 to 2400 s over 48 h. Lanes were cut into 8-mm slices, melted in 0.1 N HCl and analyzed by scintillation counting. F released values represent the fraction of total counts per minute which migrated from the cell block into the gel. Control F released values varied from 0.02 to 0.07 for all cell lines.
Quanti®cation of single strand DNA breaks (SSB) in FdUrd-treated cells with alkaline elution Con3 and dutE7 cells were plated and labeled with 0.03 lCi/ml [2-
14 C]thymidine for 48 h prior to incubation with 100 nM FdUrd for 10, 16 or 24 h. Control samples were chased for 10 h. Alkaline elution was performed as described previously [4, 15] . Cells were collected in 15 mM EDTA/PBS, and approximately 300 000 cells were loaded onto a Nucleopore polycarbonate ®lter (pore size 2 lm; Costar), washed with PBS and lysed in a solution of 2% sodium dodecyl sulfate (SDS), 0.05 M glycine and 0.02 M Na 2 -EDTA, pH 9.6. Cells were further digested with 0.5 mg/ml proteinase K in the described lysis buer for 30 min. DNA was then eluted by perfusing the ®lter with tetrapropylammonium hydroxide solution, pH 12.2, containing 0.02 M EDTA and 0.1% SDS, at a rate of 2 ml/h for 10 h. Eluted material was collected in fractions at 2-h intervals. The radioactivity in each fraction and that remaining on the ®lter were measured with scintillation counting. Cells irradiated on ice with 1.5 Gy were analyzed as external standards as described previously [4] . Data are expressed as the percent of radioactivity in a given fraction relative to the total amount of radioactivity in the sample.
Results
Eect of dUTPase expression on FdUrd-induced single-strand break formation Previous PFGE studies have revealed that dutE expression can partially protect dutE7 cells from FdUrdinduced DNA double strand breaks (DSB) [5] . We used alkaline elution to examine DNA from FdUrd-treated con3 and dutE7 cells and thereby determine whether SSB formation in parental DNA strands was inhibited in dutE7 cells as well. Figure 2A ,B contain data from a representative elution experiment of DNA from con3 and dutE7 cells treated with 100 nM FdUrd for 10, 16 or 24 h. Although there was no dierence in basal SSBs between the two cell lines, after either 16 or 24 h of FdUrd treatment there was signi®cantly less damage in dutE7 than con3 cell DNA. To examine the kinetics of SSB formation in both cell lines, values for the third fraction from several experiments were combined and plotted (Fig. 3) as previously described [4] . Parental strand SSB accumulation measured in con3 DNA at 10 or 16 h was comparable to that measured in dutE7 DNA at 16 or 24 h, respectively. Pharmacological speci®city of dUTPase-mediated protection from drug treatments To evaluate the pharmacological speci®city of the protective eects of dutE expression, we treated dutE7 and con3 cells with two other known TS inhibitors, CB3717 and MTX. After 24 h treatment with 100 lM CB3717, dutE7 cells were threefold less sensitive to CB3717-induced loss of clonogenicity, and twofold less sensitive to CB3717-induced DNA fragmentation (Figs. 4A and 5A). Similarly, dutE7 cells treated with 500 nM MTX were 1.5-fold less sensitive than con3 cells to MTX-induced cytotoxicity (Fig. 4B) . There was no signi®cant MTX-induced DNA fragmentation at 24 h (Fig. 5B) . After a 48-h exposure to CB3717, dutE7 and con3 cells were comparable in their loss of clonogenicity, even though dutE7 cells were still twofold less sensitive to CB3717-induced DNA fragmentation (Fig. 5A) . Similarly, MTX cytotoxicity was comparable in the two cells lines at 48 h when dutE7 cells were threefold less sensitive to MTX-induced DNA fragmentation. MTX-induced DNA damage and cytotoxicity were reversible with 10 lM thymidine at both 24 and 48 h (data not shown). DutE7 and con3 cells were equally sensitive to 6 lM 2-CdA, a DNA synthesis inhibitor whose actions are independent of dTTP or dUTP levels (Figs. 4C and 5C ).
Cell line speci®city of dUTPase-mediated protection from FdUrd treatment
We also examined the eects of dutE expression in a second gastrointestinal tumor cell line, HuTu80. Following retroviral infection with pLNCX.dutE, two clones were isolated, 80 C and 80 K, which had dUTPase activities of 51.8 5.6 and 59.7 9.0 pmol/ min per lg protein, respectively, compared with 19 1.6 pmol/min per lg protein in parental HuTu80 cells. The dutE-expressing HuTu80 clones were as sensitive as the parental line to the cytotoxic and DNAdamaging eects of FdUrd (Fig. 6 ). There was also no dierence in FdUrd-induced SSB formation between HuTu80 cells and dutE clones 80 C and 80 K (data not shown).
Discussion
One question that remained unanswered by our previous work was whether the reduction in FdUrd-induced DSB formation aorded by dUTPase expression was the result of protection from parental strand SSB formation. Figures 2 and 3 indicate that, indeed, the appearance of SSBs in the parental DNA strands of FdUrd-treated 14 C remaining on the ®lter after 6 h of elution were averaged to establish a timecourse for FdUrd-induced SSB in con3 and dutE7 cells. DutE7 cells were signi®cantly less sensitive to FdUrd-induced SSB accumulation at the 16 and 24 h timepoints (P < 0.05 and P < 0.001, respectively, Student's t-test). Data are expressed as the means standard error (n 4) Con3 (h) and dutE7 (n) cells were treated with either 100 lM CB3717, 500 nM MTX or 6 lM CdA for 24 or 48 h and assayed for loss of clonogenicity. After 24 h, dutE7 cells were signi®cantly less sensitive to CB3717-induced cytotoxicity (P < 0.01, MannWhitney test). DutE7 cells were also less sensitive to MTX-induced cytotoxicity at 24 h (P < 0.02, Student's t-test). However, by 48 h of drug treatment, there were no dierences in either CB3717-or MTX-induced cytotoxicity between the two cell lines. There was also no dierence in CdA sensitivity between con3 and dutE7 cells. Data are expressed as the means standard error (n ³ 5) dutE7 cells was delayed by about 6±8 h, compared with their time course of appearance in con3 cells. This result, and the observation that the appearance of FdUrd-induced SSBs precedes DSB formation, reinforce the model that FdUrd-induced DSBs arise from processing of previously created parental strand SSBs, in some manner which has yet to be determined. However, the observation that dutE expression inhibits SSB formation argues against another previously proposed model which suggests that parental SSBs arise from inecient or abortive repair of uracil that appears in DNA as a result of spontaneous deamination of cytosine residues in the parental strand [6, 16] . If this second model were correct, there would be no dierence in SSB formation between con3 and dutE7 cells as dUTPase would not aect excision of uracil from the parental DNA strand. We recently proposed an alternative model in which parental strand SSB result from the attempted mismatch repair of dA/dU base pairs following incorporation of dUTP into the nascent strand [20] . The ability of dutE to inhibit SSB formation in HT29 cells is consistent with this model.
Another question that remained unanswered in our previous study was whether the protection from FdUrdinduced DNA damage and cytotoxicity was in part due to reduced incorporation of FdUTP into DNA. We addressed this question indirectly by testing the sensitivities of con3 and dutE7 cells to other TS inhibitors. DNA fragmentation and loss of clonogenicity were both diminished in dutE7 cells treated with either CB3717 (which inhibits TS directly) or MTX (which inhibits TS indirectly, by depleting reduced folate cofactors). This result supports the hypothesis that the protective eects of dutE expression in HT29 cells are related to TS inhibition in general, and not to FdUrd treatment specifically. As was the case with FdUrd, protection from cytotoxicity was dependent on the length of drug exposure for both of these drugs, with statistically signi®cant protection observed after 24 h drug treatment but not after 48 h treatment (Fig. 4) . To con®rm that the protective eects of dUTPase expression in this cell line are indeed due to its antagonism of the consequences of TS inhibition, and not to some less speci®c eect on repair of DNA damage, we challenged con3 and dutE7 cells with CdA, which has no known eect on TS (Fig. 4C) . Neither CdA-induced DNA fragmentation nor cytotoxicity were prevented by dUTPase expression in this cell line. These results further support the expected speci®city of dUTPase protection against agents whose DNA damaging eects occur via TS inhibition.
The data also suggest that uracil misincorporation/ misrepair may contribute more to drug-induced DNA Fig. 5A±C Drug-induced DNA DSB formation in con3 and dutE7 cells as measured by PFGE. Con3 (h) and dutE7 (n) cells were treated as described in Fig. 4 legend and assayed for DNA DSB formation with PFGE. Data are expressed as the means standard error (n ³ 4) of the fraction of DNA released in the gel (F released ). DutE7 cells were signi®cantly less sensitive to CB3717-induced DNA fragmentation at both the 24 and 48 h timepoints (P < 0.0001 and P < 0 0005, respectively, Student's t-test). DutE7 cells were also less sensitive to MTX-induced DNA DSB at the 48 h timepoint (P < 0.005). The solid line represents background DNA fragmentation for both cell lines damage than cytotoxicity, in HT29 cells. DutE7 cells were signi®cantly protected from DNA damage under conditions where they were equally sensitive to druginduced cytotoxicity (Fig. 5) . This result further suggests that the observed cytotoxicity was not entirely dependent upon DNA DSB formation. After treatment with MTX for 48 h, dutE7 cells suered a 90% loss in clonogenicity with no apparent DNA DSB formation (Figs. 5B and 6B ). This cytotoxicity did not appear to result from purine depletion as it was completely reversible with 10 lM thymidine (data not shown).
Finally, to test the cell line speci®city of dUTPase protection from the eects of TS inhibition, we derived clones from another gastrointestinal tumor cell line, HuTu80, whose response to FdUrd we and others have previously documented [3, 22] . In contrast to the case in the HT29 clones, dutE expression conferred no protection from FdUrd in HuTu80 cells (Fig. 6 ). This observation is supported by work from other laboratories which suggests that the contributions of uracil misincorporation/misrepair to FdUrd cytotoxicity vary between cells lines [1] . The inability of dutE to protect HuTu80 cells could result from several factors. HuTu80 cells have a relatively high level of endogenous dUTPase activity which could already be sucient for suppressing dUTP levels. Alternatively, HuTu80 cells may be more sensitive to DNA synthesis inhibition resulting from dTTP depletion, than uracil misincorporation/misrepair.
The results from this study suggest that the role of uracil misincorporation/misrepair in cytotoxicity induced by TS inhibition is both time-and cell line-dependent. It is unclear why the protective eects of dutE expression in HT29 cells were observed after 24 h, but not after 48 h, of drug treatment. The variability in the importance of uracil misincorporation in responses of dierent cell lines to TS inhibition, however, is not unexpected. A cell's sensitivity to TS inhibition and dTTP depletion or DNA synthesis inhibition, its level of uracil DNA glycosylase activity and its ability to initiate programmed cell death processes are all factors that could contribute to this variability. We are currently investigating the role of this third factor, uracil DNA glycosylase, in FdUrd-induced cytotoxicity and DNA damage in HT29 cells.
